Cutler Group LP Lava Therapeutics Nv Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Cutler Group LP holds 1,000 shares of LVTX stock, worth $1,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,530% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.93MCall Options Held
50.2KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$3.17 Million0.28% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.02 Million1.97% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$798,4670.28% of portfolio
-
Pathway Financial Advisors LLC103KShares$156,8250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$99,4500.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $39.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...